Invitation
General information
Program
Travel & Hotel
Activities & Tours
Registration
Abstracts
Submit abstract
Links
ISBP Home

Program

Thursday September 1st 2005

 

 

SYMPOSIUM 1: Uremic Toxins

 

Chairman: R. Ward

9:00

-

9:10

Opening ISBP 2005

9:10

-

9:35

R.C. Vanholder

Gent

Uremic toxins, where are we today?

9:35

-

10:00

Z. Massy

Paris

Uremic toxins and cardiovascular risc.

10:00

-

10:25

M.J. Lysaght

Providence

Treating uremia with microencapsulated enzymes.

10:30

-

11:00

Coffee and Tea

Oral presentations 1:

 

Chairman:F. Locatelli and F. van der Sanden

11:00

-

11:15

M.M.H. Hermans

Maastricht

26: Association of serum fetuin-A (AHSG) concentrations with arterial stiffness in patients on dialysis.

11:15

-

11:30

M. Boehme

Berlin

4: Pentraxin 3 (PTX3) is elevated in hemodialysis (HD)- but not peritoneal dialysis (PD) patients and is associated with cardiovascular disease.

11:30

-

11:45

J. Axelsson

Stockholm

23: Are insulin-like growth factor (IGF)-I and its’ binding proteins (IGFBP)- 1 and -3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease patients on peritoneal dialysis?

11:45

-

12:00

T. Tokumoto

Tokyo

9: Change of bone lesion in hemodialysis patients with renal osteopathy after renal transplantation.

12:00

-

12:30

M. Ketteler

Aachen

Keynote speaker: Vascular calification in ESRD.

 

12:30

-

14:00

Buffet Lunch

 

13:00

-

14:00

Guided poster session 1 + 2

 

 

 

ISBP Award session:

Chairmen: T. Akiba and L. Smeby

 14:00

-

14:10

Presentation of the

ISBP Award 2005

 

 

 

14:10

-

14:40

Award lecture: Eberhard Ritz

Heidelberg

Cardiac death in endstage renal failure -

pathomechanisms and strategies to overcome the problem.

 

SYMPOSIUM 2: The Heart in ESRD

 

Chairman: R. Zietse

14:40

-

15:05

M. Zile

Charleston

Diastolic cardiac function.

15:05

-

15:35

E.H. Ie

Rotterdam

Pressure-volume relations in ESRD.

15:35

-

16:00

E. Paganini

Cleveland

Ultrafiltration in heart failure.

 

16:00

-

16:15

Coffee and Tea

 

Oral presentations 2:

 Chairman: B. Lindholm and A. Davenport

16:15

-

16:30

C. Chazot

Tassin

33: Gradient between predialysis plasma sodium and prescribed sodium dialysate: a cross-sectional study in a large cohort of hemodialysis patients.

16:30

-

16:45

J. M. Kong

Hong Kong

7: Efficacy of ascorbic acid for epo-resistant anemia of hemodialysis patients: a double blind placebo controlled study.

16:45

-

17:00

P. Zemanova

Pilsen

25: Is it appropriate to tune regional citrate anticoagulation during hemodialysis by ionized calcium levels?

17:00

-

17:30

M. Hammerman

St Louis

Keynote speaker: Organogenesis of the kidney - Growing New Organs in Situ.

17:30

-

18:00

ISBP General Assembly

 

 

 

 

Friday September 2nd 2005

 

SYMPOSIUM 3: Peritoneal Dialysis

 Chairman: T. Golper and P. ter Wee

9:00

-

9:20

R. Selgas

Madrid

Mesothelial transdifferentiation.

9:20

-

9:40

J. Bargman

Toronto

PD and Residual Renal Function.

9:40

-

10:00

B. Lindholm

Stockholm

PD and inflammation.

10:00

-

10:20

R.T. Krediet

Amsterdam

New fluids in PD.

10:20

-

10:50

Coffee and Tea

SYMPOSIUM 4: Hemodialysis

 Chairman: I. Ledebo and P.J. Blankestijn

10:50

-

11:15

R Schindler

Berlin

Clinical aspects of water treatment.

11:15

11:40

PJ Blankestijn

Utrecht

Volume-independent mechanisms of hypertension in hemodialysis patients.

11:40

12:05

D Fliser

Hannover

Endothelial progenitor cells in End Stage Renal Failure.

12:05

12:30

J Rotmans

Amsterdam

Sirolimus eluting stents in PTFE loops.

 

12:30

-

14:00

Buffet Lunch

13:00

-

14:00

Guided poster session 3 + 4

 

 

 

 

Oral presentations 3:

 Chairman: T. Akiba and K. Leunissen

14:00

-

14:05

Presentation of best poster awards 2005

14:05

-

14:10

Presentation of best abstract award 2005

14:10

-

14:25

Best abstract:

M. Grooteman

Amsterdam

32: Dialyser biocompatibility and flux characteristics do not influence dimethylarginine levels in chronic hemodialysis patients.

14:25

-

14:40

V. Gura

Los Angeles

15: Wearable CRRT device for continuous hemodialysis or ultrafiltration.

14:40

14:55

R. Dietrich

Hechingen

13: Development of an anti-thrombotic and anti-biofilm surface for application in vascular access technology.

14:55

15:10

C. Doelman

Eindhoven

11: Stenosis detection in failing hemodialysis access fistulas and grafts: comparison of Color Doppler Ultrasonography, Contrast-Enhanced Magnetic Resonance Angiography and Digital Subtraction Angiography.

 

 

15:10

-

15:30

Coffee and Tea

 

 

SYMPOSIUM 5: The future of Dialysis

 Chairman: S. di Giulio

 15:30

-

16:00

O. Devuyst

 Brussels

From genetics to genomic medicine: Perspectives for dialysis patients.

16:00

-

16:30

F. Locatelli

Lecco

Which issues should be addressed in Future trials in Dialysis.

16:30

-

16:45

Discussion

16:45

-

16:50

Concluding remarks and announcement of ISBP 2006

 

 

 

Poster session 1
Thursday September 1st 2005
Chairman:
 

 P1 [Abstract nr 1]
Successful Use of Albumin Dialysis for Hypoxic Liver Failure After Cardiac Surgery.
O.T. Corsmit, C.V. Elzo Kraemer, J.J. Maas, R.J.M. Klautz, P.C.M. van den Berg
Leiden University Medical Center, Leiden, The Netherlands

P2 [Abstract nr 2]
Adiponectin in Long-term Hemodialysis Patients.
M. Kubo, K. Tago
Tago Kidney and Urology Clinic, Japan

P3 [Abstract nr 3]
Is Hypertension or Hypotension the True Problem in Patients on Extracorporeal Dialysis (RDT)?
G. Calabrese, A. Mazzotta, G. Vagelli, M. Gonella
Renal Unit, Ospedale S. Spirito, Casale Monferrato, Italy

P4 [Abstract nr 5]
Risk Factors for Lower Limb Amputations (LLA) in Incident Haemodialysis Patients from Two European Countries.
A. Ferreiraa, A. Di Benedettob, P. Poncec, S. Cesareb, J. Kirchgessnerd, D. Marcellid
aHemodial, Clínica de Diálise, Vila Franca de Xira, Portugal, bFresenius Medical Care, Italy, cFresenius Medical Care Portugal, dClinical Management Europe, FreseniusMedical Care, Bad Homburg, Germany

P5 [Abstract nr 6]
Inflammation and Cardiovascular Disease Markers in Haemodialysis Patients.
P. Matiasa, I. Airesa, C. Jorgea, S. Marumb, H. Lagec, C. Gila, F. Gomesa, E. Arranhadoc, A. Ferreiraa
aHemodial, Vila Franca de Xira, bIntensive Care Unit, cLaboratory of Immunology, Hospital Curry Cabral, Lisbon

P6 [Abstract nr 8]
Study of Countermeasures to Prevent Di(2 etylehexyl) Phtalate Elution from Blood Tubing
Y. Kan-noa, T. Shibamotoa, N. Itob, Y. Yoshimotoa, M. Fukasea, N. Teradaa, M. Kuwaharaa, S. Sasakia
aDepartment of Blood Purification, Tokyo Med and Dent Univ (Japan), bNIKKISO Medical Co Ltd, Tokyo, Japan

P7 [Abstract nr 10]
Acute Renal Failure in Patients with Severe Hyponatremia.
E.J. Hoorna, J. Lindemansb, R. Zietsea
aDepartment of Internal Medicine, bDepartment of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands

 

 

Poster session 2
Thursday September 1st 2005
Chairman:
  

 

P8 [Abstract nr 12]
Vascular Access Intervention Therapy Using Gadolinium for Patients with Iodine Allergy.
M. Fukasawaa, H. Skamotob, M. Takedaa
aDepartment of Urology, University of Yamanashi, bDepartment of Clinical Radiology, University of Yamanashi, Japan

P9 [Abstract nr 14]
Use of The Organized Cuff Shaving in the Procedures of Substitution of Septic Permanent Tunneled Central Venous Catheters.
B. Ricciardia, A. Saranitia, F. Gittoa, A. Saporitaa, A. Pontorieroa, A. Ragusaa, A. Scirèa, G. Bellinghierib
aU.O.C. di Nefrologia e Dialisi Milazzo – Lipari, A.U.S.L. n 5 Messina, bChair of Nephrology, Messina University, Italy

P10 [Abstract nr 16]
Does a Reduction of Adhesion Molecules by LDL-apheresis Have a Role in The Treatment of Sudden Hearing Loss?
A. Ramunnia, N. Quarantab, M.T. Saliania, R.M. Fallacarab, R. Riac, G. Ranieri
aSection of Nephrology, Department of Internal and Public Medicine, bOtolaryngology Clinic ‘G. Lugli’, Department of Opthalmology and Otorhinolaryngology, cSection of Internal Medicine, Department of Biomedical Sciences and Human Oncology, University of Bari, Italy

P11 [Abstract nr 17] Replacement Therapy of Liver Detoxifying Function by MARS in Acute on Chronic Failure.
R. Marangoni
Liver Unit, S. Giuseppe Hospital, Milan, Italy

P12 [Abstract nr 18]
Association Active C Protein/Haemoperfusion on Adsorbent Cartridge with ‘B Polymyxin’, in a Patient Affected by Acute Kidney Failure and Sepsis.
B. Ricciardia, A. Pontorieroa, D. Grassob, A. Saranitia, F. Gittoa, A. Saporitaa, A. Ragusaa, C. Morminab, M. Scibiliab,S. Bolignanob, M. Frigioneb, G. Bellinghieric
aUnit of Nephrology and Dialysis Milazzo/Lipari, bUnit. of Anaesthesia and Reanimation, Milazzo Hospital A.U.S.L. n 5 Messina, cChair of Nephrology of Messina University, Italy

P13 [Abstract nr 19]
Existence of Microbial Contaminations in Endotoxin Free Dialysate.
I. Masakanea, H. Kanedaa, Y. Kurodaa, S. Moriyaa, Y. Tannnoa, H. Ohgiyab
aYabuki Hospital, bIzumi Central Hospital,Yamagata, Japan

P14 [Abstract nr 20]
On-line Hemodiafiltration is Effective to Keep Muscle Volume in CKD Patients.
I. Masakanea, H. Sekib, R. Atsumib, Y. Shishidob
aYabuki Hospital, bMidorino-sato Clinic, Yamagata, Japan

 

Poster session 3
Friday September 2nd 2005
Chairman:
 

 P15 [Abstract nr 21]
Examination of 2 Cases That Enforces Endotoxin Hemoadsorption Treatment for Septic Shock.
Y. Minagawa
Kuji Hospital, Kuji, Japan

P16 [Abstract nr 22]
Experiences with CVVH As a New Treatment Modality in Our Paediatric and Neonatal ICU.
L. Koster-Kamphuis, A. van As
University Children’s Hospital St Radboud Nijmegen, The Netherlands

P17 [Abstract nr 24]
Hypotension in Peritoneal Dialysis-more than Hypovolemia.
M. Avramovic
Institute of Nephrology and Hemodialysis, Medical School of Nis, Serbia and Montenegro

P18 [Abstract nr 27]
Optimum Sieving and Biocompatibility Profiles of The New High-Flux Dialysis Membrane Purema® H.
D.H. Krietera, A. Barasinskia, A. Morgenrothb, H.-D. Lemkec, C. Wannera
aDepartment of Medicine, Division of Nephrology, University of Würzburg, bDialysis Center Elsenfeld, cMembrana Research, Obernburg, Germany

P19 [Abstract nr 28]
Disturbed Mineral Metabolism is Associated with Cardiovascular Morbidity in Dialysis Patients.
M. Noordzija, J.C. Korevaara, E.W. Boeschotenb, F.W. Dekkerc, W.J. Bosd, R.T. Krediete
aDept. of Clinical Epidemiology and Biostatistics, AMC, University of Amsterdam, bHans Mak Institute, Naarden, cDept. of Clinical Epidemiology, LUMC, University of Leiden, dDept. of Internal Medicine, St. Antonius Hospital, Nieuwegein, eDept. of Nephrology, AMC, University of Amsterdam, The Netherlands

P20 [Abstract nr 29]
Investigation of Activated Blood Substances in the Measuring of Whole Blood Clotting Time During Hemodialysis.
K. Abea, T. Hashimotoa, M. Nokia, T. Shibamotob, M. Hoshinoa
aHemodialysis Unit, SEISHOUKAI Memorial Hospital (Japan), bDepartment of Blood Purification, Tokyo Med. and Dent. Univ., Tokyo, Japan

P21 [Abstract nr 30]
The Association Between Body Mass Index and All-cause Mortality in Dutch Incident Hemodialysis Patients.
R. de Mutserta, F. van der Sman-de Beera, J.S. Mourera, E.W. Boeschotenb, R.T. Kredietc, F.W. Dekkerc
aLUMC, Leiden, bHans Mak Institute, Naarden, cAMC, Amsterdam, The Netherlands

 

Poster session 4
Friday September 2nd 2005
Chairman:
 

 P22 [Abstract nr 31]
Effects of GI Medication to The Mineral Metabolism Control in Patients Undergoing Hemodialysis.
N. Kimataa, T. Satob, K. Abec, M. Hoshinoc, T. Akibaa
aDepartment of Blood Purification, Kidney Center, Tokyo Women’s Medical University, bUrayasu-ekimae Clinic, cSaishokai Memorial Hospital, Japan

P23 [Abstract nr 34]
Intradialytic Hemodynamic Instability: Effects of Cool Temperature Dialysate, Citrate and Platelet Activity.
M. Grittersa, P. Borgdorffb, M. Schoorlc, M.P.C. Grootemand, P.C.M. Bartelsc, G.J. Tangelderb, M.J. Nubéa
aNephrology, Medical Center Alkmaar, bPhysiology, VU University, cBiochemistry, Medical Center Alkmaar, dNephrology, VU University Medical Center, Amsterdam, The Netherlands

P24 [Abstract nr 35]
Experiences with Therapeutic Plasma Exchange (TPE) in Our Paediatric Dialysis Unit During Ten Years.
L. Koster-Kamphuis, N. van de Kar
University Children’s Hospital St Radboud Nijmegen, The Netherlands

P25 [Abstract nr 36]
Low-Density Lipoprotein Apheresis Ameliorated the Digital Gangrene Caused by Repeated Puncture into Subcutaneously Fixed Superficial Brachial Artery in a Hemodialysis Patient.
K. Tsuchida, Y. Takemoto, H. Kuroki, I. Go, M. Matsuyama, R. Yoshimura, K. Sugimura, T. Nakatani
Department of Urology, Osaka City University Graduate School of Medicine, Osaka, Japan

P26 [Abstract nr 37]
Therapeutic Plasma Exchange (TPE) with Haemonetics PCS for the Treatment of Acute Hypertriglyceridemia.
A. Griskevicius, J. Audzijoniene, A. Baublys
Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania

P27 [Abstract nr 38]
Bidialysis On Line: A New Solution for Ipercatabolic or High Body Weight Hemodialysis Patients
S. Giorgio, C. Stefano, C. Roberto, F. Antonia, N. Laura, C. Carmela
Department of Nephrology, Tor Vergata University, Rome, Italy

P28 [Abstract nr 39]
Kinetic Studies on Urea Extraction with Hemodialysis in Children and Adolescents by On-Line Monitoring of Dialysate Urea
A.D. Marina, K.-E. Bonzel, T. Drossert, M. Kreuzer, R. Büscher, B. Kranz, P. F. Hoyer
Clinic for Paediatric Nephrology, University Children’s Hospital Essen, Germany

ISBP_2005_program.pdfISBP_2005_program.pdfISBP_2005_program.pdf